In 2023, the Canadian biotech landscape showed stability, largely maintaining the financing levels of the previous year (USD 451 million in 2023 vs. USD 460 million in 2022), but falling short of the record year of 2021. Ontario once again proved to be Canada’s most active province, with the highest number of biotech companies and … Continue reading Canadian Life Science Trend Analysis 2024
Category: Canada
Yearly Life Sciences Reports of Canada
Canada Life Science Trend Analysis 2023
Canadian biotech private equity investment has grown steadily over the past four years, but appears to have hit its peak in 2021 – in 2022, the value of biotech equity financings failed to match the record levels of the previous year (2022: USD 599 million vs. 2021: USD 841 million). Ontario is Canada’s most active … Continue reading Canada Life Science Trend Analysis 2023
Canada Life Science Trend Analysis 2022
In 2021, both Canadian and foreign investors closed overall larger venture capital deals than ever, resulting in an increasingly robust life science industry in Canada. In the Biotech – Therapeutics and Diagnostics sector alone, the three top financing deals were each worth at least 100 million USD. For more details on the Biotechgate data, see … Continue reading Canada Life Science Trend Analysis 2022
Canada Life Science Market Trend Analysis 2021
In 2020, the total value of biotech equity financing in Canada, as well as the number of rounds, were slightly higher than in 2019 and the highest since 2016. Canadian companies currently have more than 700 human therapeutics in their pipelines and the country remains one of the strongest life science markets in the world. … Continue reading Canada Life Science Market Trend Analysis 2021
Canadian Life Science Market Trend Analysis 2020
Together with our partners – Montreal Invivo, BioAlberta and BIOTECanada – we are happy to present an extended annual report on the Canadian life science market. Besides the usual statistics about companies, products and investments, the new format of the report includes data on clinical trials acquired from the new section of Biotechgate database.
Canadian Life Science Market Trend Analysis 2019
This month we are presenting the annual trend report for the Canadian life science market that shows the strong position of the country in the global biotech industry. The total financing amount of the three largest rounds of 2019 alone exceeded a quarter billion USD. Download the report Would you like to be notified about … Continue reading Canadian Life Science Market Trend Analysis 2019
Canadian Biotech Market Trend Analysis 2018
Biotechgate presents the annual life science and biotech market trend analysis for Canada. There are currently around thousand biotechnology and around a hundred pharma companies there, excluding subsidiaries of companies headquartered in other countries. The therapeutics sector is remarkably strong and three large financing round has been noted in the last 12 months. Canadian Biotech … Continue reading Canadian Biotech Market Trend Analysis 2018
Canadian Life Sciences Trend Analysis 2017
This month we look at the Canadian life science market. 2016 was a particularly good year when it comes to investing in biotech companies there. The major financing rounds accumulated to over half a billion USD and we can see the continuation of the trend in 2017. Please click on the link below for the … Continue reading Canadian Life Sciences Trend Analysis 2017
Canadian Life Sciences Trend Analysis 2016
The amount of private Canadian biotech companies founded in 2015 was the lowest in at least 10 years, with just two new businesses entering the field. However private Biotech funding has enjoyed a small increase in total investment in H1 of 2016 when compared to the final months of last year. Download the full trend … Continue reading Canadian Life Sciences Trend Analysis 2016
Canadian Life Sciences Trend Analysis 2014
In 2013 the venture capital raised by Biotechnology companies in Canada almost doubled (93% increase) compared to the previous year’s figure, to reach a total of USD 139m. The majority of Biotech products in the industry belong to the area of oncology, followed by products developed for nervous system and for Infectious diseases indications. Distributors, … Continue reading Canadian Life Sciences Trend Analysis 2014